OSTARINE NORDIC FUSION at a Glance
Ostarine Nordic Fusion is a selective androgen receptor modulator (SARM) from the aryl-propionamide class, designated MK-2866 in research literature. This compound selectively modulates androgen receptors with demonstrated tissue selectivity in preclinical models. Nordic Fusion formulation represents laboratory-grade material suitable for in-vitro research applications. The compound has been extensively studied in over 25 clinical investigations involving more than 1,700 subjects according to manufacturer reports. Researchers at Stroid UK Shop examine this SARM for its unique receptor binding profile and oral bioavailability characteristics in laboratory settings.
Laboratory Applications
Research teams investigate Ostarine for its mechanism involving selective androgen receptor binding with reduced androgenic effects compared to traditional compounds. Studies focus on its potential in cancer-related cachexia models, stress urinary incontinence research, and sarcopenia investigations. The compound demonstrates oral bioavailability, making it valuable for researchers examining SARM pharmacokinetics. Laboratories exploring Ostarine MK-2866 compounds analyse its tissue-selective properties and receptor modulation patterns. Research applications extend to bone density studies and muscle biology investigations, where scientists examine the compound’s anabolic activity profile. Teams studying SARMs research chemicals compare Ostarine’s selectivity ratios against other androgen receptor modulators. Additionally, researchers investigating metabolic pathways often examine this compound alongside research peptides for comprehensive tissue biology studies.
Technical Specifications
| CAS Number | 841205-47-8 |
|---|---|
| Molecular Formula | C₁₉H₁₄F₃N₃O₃ |
| Molecular Weight | 389.33 g/mol |
| Classification | Non-steroidal SARM (aryl-propionamide) |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | Androgen receptor modulation studies |
Laboratory Compliance
This Ostarine Nordic Fusion formulation is manufactured exclusively for in-vitro research purposes and laboratory investigations. The compound is not intended for human consumption, clinical use, or any therapeutic applications. Research facilities must maintain appropriate handling protocols and storage conditions. All laboratory personnel should follow institutional guidelines for research chemical handling. This product is restricted to qualified research institutions and licensed laboratories conducting studies on selective androgen receptor modulators and related biochemical pathways.
